State Street Corp Xencor Inc Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Xencor Inc stock. As of the latest transaction made, State Street Corp holds 3,817,610 shares of XNCR stock, worth $29.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,817,610

Previous 3,683,715 3.63%

Holding current value

$29.6 Million

Previous $39.2 Million 23.44%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$7.52 - $11.26 $1.01 Million - $1.51 Million	133,895 Added 3.63%	3,817,610 $30 Million
Q1 2025 May 15, 2025	BUY	$10.64 - $24.13 $5.14 Million - $11.7 Million	482,802 Added 15.08%	3,683,715 $39.2 Million
Q4 2024 Feb 14, 2025	BUY	$19.43 - $26.84 $1.59 Million - $2.19 Million	81,623 Added 2.62%	3,200,913 $73.6 Million
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $3.66 Million - $5.05 Million	-233,086 Reduced 6.95%	3,119,290 $62.7 Million
Q2 2024 Aug 14, 2024	SELL	$18.21 - $24.5 $16.1 Million - $21.6 Million	-883,067 Reduced 20.85%	3,352,376 $63.5 Million
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $16.9 Million - $24.1 Million	908,587 Added 27.31%	4,235,443 $93.7 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $5.76 Million - $7.46 Million	348,255 Added 11.69%	3,326,856 $70.6 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $2.51 Million - $3.17 Million	-124,976 Reduced 4.03%	2,978,601 $60 Million
Q2 2023 Aug 14, 2023	SELL	$24.77 - $29.9 $4.37 Million - $5.28 Million	-176,591 Reduced 5.38%	3,103,577 $77.5 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $3.22 Million - $4.59 Million	124,117 Added 3.93%	3,280,168 $91.5 Million
Q4 2022 Feb 14, 2023	SELL	$24.79 - $30.86 $2.46 Million - $3.07 Million	-99,401 Reduced 3.05%	3,156,051 $82.2 Million
Q3 2022 Nov 15, 2022	BUY	$24.62 - $32.44 $183,936 - $242,359	7,471 Added 0.23%	3,255,452 $84.6 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $5.51 Million - $8.1 Million	279,080 Added 9.4%	3,247,981 $88.9 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $13 Million - $20.3 Million	488,131 Added 19.68%	2,968,901 $79.2 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $3.45 Million - $4.46 Million	-102,563 Reduced 3.97%	2,480,770 $99.5 Million
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $690,544 - $803,870	-22,530 Reduced 0.86%	2,583,333 $84.4 Million
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $652,853 - $849,679	19,017 Added 0.74%	2,605,863 $89.9 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $5.27 Million - $6.96 Million	129,087 Added 5.25%	2,586,846 $111 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $1.88 Million - $2.45 Million	51,392 Added 2.14%	2,457,759 $107 Million
Q3 2020 Nov 10, 2020	SELL	$30.09 - $43.02 $10.7 Million - $15.3 Million	-356,094 Reduced 12.89%	2,406,367 $93.3 Million
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $18.2 Million - $21.9 Million	654,370 Added 31.04%	2,762,461 $89.5 Million
Q1 2020 May 11, 2020	BUY	$20.69 - $37.79 $43.6 Million - $79.7 Million	2,108,091 New	2,108,091 $63 Million

Others Institutions Holding XNCR

# of Institutions

202

Shares Held

81.7M

Call Options Held

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $463M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Xencor Inc Transaction History